These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [The neuroleptic malignant syndrome in an adolescent. Its treatment with dantrolene, bromocryptin and diazepam]. Real Rodríguez B; Ruibal JL; Grande Rodríguez S; Sueiro Pita B An Esp Pediatr; 1996 Jan; 44(1):60-2. PubMed ID: 8849063 [No Abstract] [Full Text] [Related]
4. Neuroleptic malignant syndrome associated with metoclopramide in a burn patient. Nachreiner R; Balledux J; Zieger M; Viegas O; Sood R J Burn Care Res; 2006; 27(2):237-41. PubMed ID: 16566575 [TBL] [Abstract][Full Text] [Related]
5. Neuroleptic malignant syndrome associated with haloperidol use in critical care setting: should haloperidol still be considered the drug of choice for the management of delirium in the critical care setting? Dixit D; Shrestha P; Adelman M BMJ Case Rep; 2013 Jul; 2013():. PubMed ID: 23853022 [TBL] [Abstract][Full Text] [Related]
6. Neuroleptic malignant syndrome complicating closed head injury. Vincent FM; Zimmerman JE; Van Haren J Neurosurgery; 1986 Feb; 18(2):190-3. PubMed ID: 3960297 [TBL] [Abstract][Full Text] [Related]
7. Neuroleptic malignant syndrome and clozapine. Reddig S; Minnema AM; Tandon R Ann Clin Psychiatry; 1993 Mar; 5(1):25-7. PubMed ID: 8102300 [TBL] [Abstract][Full Text] [Related]
8. Suspected neuroleptic malignant syndrome in a patient receiving clozapine. Ganelin L; Lichtenberg PS; Marcus EL; Munter RG Ann Pharmacother; 1996 Mar; 30(3):248-50. PubMed ID: 8833560 [TBL] [Abstract][Full Text] [Related]
9. [A cocaine-induced variant of the neuroleptic malignant syndrome. A case study]. Smidt MH; Collumbien EC Tijdschr Psychiatr; 2006; 48(5):399-404. PubMed ID: 16956032 [TBL] [Abstract][Full Text] [Related]
10. Neuroleptic malignant syndrome in a COVID-19 patient. Kajani R; Apramian A; Vega A; Ubhayakar N; Xu P; Liu A Brain Behav Immun; 2020 Aug; 88():28-29. PubMed ID: 32425332 [No Abstract] [Full Text] [Related]
13. Neuroleptic malignant syndrome complicating antipsychotic treatment of delirium or agitation in medical and surgical patients: case reports and a review of the literature. Seitz DP; Gill SS Psychosomatics; 2009; 50(1):8-15. PubMed ID: 19213967 [TBL] [Abstract][Full Text] [Related]
14. Exacerbating factors in neuroleptic malignant syndrome: comparisons between cases with death, sequelae, and full recovery. Nagamine M; Yoshino A; Sakurai Y; Sanga M; Takahashi R; Nomura S J Clin Psychopharmacol; 2005 Oct; 25(5):499-501. PubMed ID: 16160631 [No Abstract] [Full Text] [Related]
15. Early bicarbonate loading and dantroline for ziprasidone/haloperidol-induced neuroleptic malignant syndrome. Strawn JR; Keck PE J Clin Psychiatry; 2006 Apr; 67(4):677. PubMed ID: 16669738 [No Abstract] [Full Text] [Related]
16. Neuroleptic malignant syndrome in an adolescent head trauma patient. Trasmonte J; Dayner J; Barron TF Clin Pediatr (Phila); 1999 Oct; 38(10):611-3. PubMed ID: 10544869 [No Abstract] [Full Text] [Related]
17. Neuroleptic malignant syndrome during haloperidol treatment in a cancer patient. A case report. Tanaka K; Akechi T; Yamazaki M; Hayashi R; Nishiwaki Y; Uchitomi Y Support Care Cancer; 1998 Nov; 6(6):536-8. PubMed ID: 9833304 [TBL] [Abstract][Full Text] [Related]
18. Management of suspected neuroleptic malignant syndrome. Velamoor VR; Swamy GN; Parmar RS; Williamson P; Caroff SN Can J Psychiatry; 1995 Nov; 40(9):545-50. PubMed ID: 8574990 [TBL] [Abstract][Full Text] [Related]
20. [Malignant neuroleptic syndrome and Clostridium difficile: causal association or mere coincidence?]. Salas de Zayas R; Cerdeño Gómez C; Dolera Moreno C; Mármol E Med Intensiva; 2012; 36(1):63. PubMed ID: 22154227 [No Abstract] [Full Text] [Related] [Next] [New Search]